Admission Date:  [**2135-5-2**]              Discharge Date:   [**2135-5-30**]  Date of Birth:  [**2070-1-31**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**Last Name (NamePattern1) 4377**] Chief Complaint: Hypoxia, hypotension  Major Surgical or Invasive Procedure: None  History of Present Illness: 65 year old male with Non hodgkins lymphoma on HCD122 chemo protocol, prior mycobacterium xenopi and MRSA PNA, emphysema, HTN, s/p PEG placement, who was admitted to ED from oncology clinic appt with right shoulder/chest pain, mild hypoxia, hypotension, and tachycardia.
The patient had gone to oncology clinic for scheduled chemo (CD40 inhibitor study drug), when found to have new right-sided chest/shoulder pain, hypoxia to high 80s/low 90s on RA, tachycardia to 120s, and hypotension to 83/58.
Patient describes 1 week h/o right sided pleuritic pain, fatigue, malaise, and decreased PO intake.
Denies fever, chills, diarrhea, wheezing, chest pain, palpitations.
He has had multiple hospitalizations in last year, the most recent being [**Date range (1) 55849**] for RSV infection - discharged on 10 days of levaquin for bacterial superinfection ppx.
In the clinic, he was given heparin bolus 5000 units for concern of PE given increased lymphedema on right side and risk factors, and sent to ED.
Patient's outpatient oncologist was made aware, pt was transferred to [**Hospital Unit Name 153**] for further care of her sepsis, hypoxia.
Has been refractory to multiple chemotherapeutic regimens, currently enrolled on protocol DF#08-019 which is a Phase I/A/II multicenter open label study of HCD122 which is administered intravenously once weekly for 4 weeks -s/p 4 cycles of R-CVP -s/p 4 cycles of R-CHOP -s/p Zevalin in [**7-/2130**] -s/p Rituximab, fludarabine, and mitoxantrone in [**4-/2131**] -s/p 6 cycles bendamustine in [**2-/2132**] -s/p radiation therapy mesenteric mass in [**9-/2133**] -s/p radiation therapy to left pelvic lymphadenopathy causing ureteral obstruction) in [**1-/2134**] -s/p 1 course [**Hospital1 **] [**Date range (1) **]/[**2134**] .
Other Medical History: 1) Mycobacterium xenopi infection since [**2132-12-26**]: Had received one year of Levofloxacin/Azithromycin therapy until [**3-/2134**] with good effect.
Per ID, will need to continue for a total 6 month course (finish [**2135-2-16**]), after which he will be switched to azithromycin alone.
s/p left VATS w wedge resections in [**2133**] for pulmonary nodules 2) C difficile colitis diagnosed during hospitalization in [**9-3**].
He was initially treated on PO metronidazole then converted to PO vancomycin on [**2134-9-22**].
3) During last [**Hospital1 **] admission ([**Date range (1) 32408**]), he had a MRSA UTI, treated with a total of 2 weeks of Vancomycin and then Bactrim.
5) Repeat admission for failure to thrive resulted in PEG tube placement on [**2135-1-5**].
6) Emphysema with smoking history  Social History: The patient has been living at sister's house, prior to this had been at Colony house for rehabilitation following multiple extended hospitalizations over the past several months.
Physical Exam: On admission GENERAL: Elderly male with nasal cannula in place, not using accessory muscles, in NAD HEENT: Sclerae anicteric.
LYMPH NODES: Possible small right anterior cervical at base/supraclavicular node.
No LE edema NEUROLOGIC: grossly nonfocal   Pertinent Results: [**2135-5-2**] 09:00AM   GRAN CT-[**Numeric Identifier 55506**]* [**2135-5-2**] 09:00AM   PLT SMR-NORMAL PLT COUNT-245 [**2135-5-2**] 09:00AM   HYPOCHROM-NORMAL ANISOCYT-NORMAL POIKILOCY-NORMAL MACROCYT-NORMAL MICROCYT-NORMAL POLYCHROM-NORMAL [**2135-5-2**] 09:00AM   NEUTS-64 BANDS-12* LYMPHS-7* MONOS-9 EOS-0 BASOS-0 ATYPS-0 METAS-4* MYELOS-3* PROMYELO-1* [**2135-5-2**] 09:00AM   WBC-16.3* RBC-2.85* HGB-10.2* HCT-30.2* MCV-106* MCH-35.9* MCHC-33.9 RDW-18.4* [**2135-5-2**] 09:00AM   TOT PROT-5.2* ALBUMIN-3.3* GLOBULIN-1.9* CALCIUM-9.1 PHOSPHATE-5.1* MAGNESIUM-1.7 URIC ACID-8.2* [**2135-5-2**] 09:00AM   LIPASE-11 [**2135-5-2**] 09:00AM   ALT(SGPT)-18 AST(SGOT)-22 LD(LDH)-262* ALK PHOS-95 AMYLASE-30 TOT BILI-0.3 DIR BILI-0.2 INDIR BIL-0.1 [**2135-5-2**] 09:00AM   UREA N-57* CREAT-2.4* SODIUM-142 POTASSIUM-4.4 CHLORIDE-103 TOTAL CO2-19* ANION GAP-24* [**2135-5-2**] 09:20AM   PT-14.9* INR(PT)-1.3* [**2135-5-2**] 09:20AM   D-DIMER-767* [**2135-5-2**] 10:25AM   LACTATE-3.1* [**2135-5-2**] 03:22PM   LACTATE-2.6* [**2135-5-2**] 03:22PM   TYPE-ART PO2-86 PCO2-29* PH-7.42 TOTAL CO2-19* BASE XS--3 [**2135-5-2**] 03:50PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG [**2135-5-2**] 03:50PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.026 [**2135-5-2**] 03:50PM URINE  OSMOLAL-345 [**2135-5-2**] 03:50PM URINE  HOURS-RANDOM CREAT-43 SODIUM-25 [**2135-5-2**] 11:41PM   CALCIUM-7.9* PHOSPHATE-5.8* MAGNESIUM-2.3 [**2135-5-2**] 11:41PM   GLUCOSE-93 UREA N-49* CREAT-2.0* SODIUM-140 POTASSIUM-4.3 CHLORIDE-112* TOTAL CO2-18* ANION GAP-14  MICRO: RESPIRATORY CULTURE (Final [**2135-5-6**]):       MODERATE GROWTH OROPHARYNGEAL FLORA.
Specifically, no evidence of new parenchymal infectious process  DISCHARGE LABS: WBC: 13.4/9.2/28.1/347 CHEM 7: 136/4/96/25/29/1.3/97  Brief Hospital Course: 65 year old male with refractory Non hodgkins lymphoma on trial anti CD40 chemo protocol with a complicated medical history including COPD and M. xenopi infection as well as multiple recent pneumonias who presented with sepsis requiring brief ICU stay in the setting of a MRSA pneumonia.
Treated with vancomycin and completed course.
Developed C. diff and was treated with oral vancomycin starting [**2135-5-21**], total duration of treatment should be 2 weeks every 6 hours.
Patient should then continue on prophylaxis of vancomycin 125mg po bid indefinitely.
MRSA Pneumonia, sepsis:  Given the patient's hypoxia and right-sided pleuritic chest pain upon presentation, a CTA was done which failed to find a PE.
The patient completed a 14 day course of vancomycin during which his clinical status as well as his pleuritic chest pain improved dramatically.
By the end of his treatment course he was able to ambulate on room air without desaturation.
He was started on PO vanco for a total of 2 weeks, last dose should be the evening on [**2135-6-4**] and then should be continued [**Hospital1 **] indefinitely as above.
Additionally, he was treated with IvIg on [**2135-5-29**] given persisently low IgG levels.
Hypotension: The patient's home diltiazem was held given his initial hypotension.
A cardiology consult was called and recommended uptitrating beta-blockage in the setting of a multi-factorial atrial and multi-focal atrial tachycardia from deconditioning, COPD, and progressive failure to thrive.
Non Hodgkins Lymphoma:  Continued on prophylactic acyclovir and fluconazole as well as monthly pentamidine.
Per his primary oncologist, the CD40 study drug could not be obtained for the patient until 2 weeks after his completion of antibiotics (to end [**2135-6-4**]).
He was continued on home fluticasone and combivent and nebs prn.
# Mycobacterium Xenopi: The patient was continued on Azithromycin q tuesday.
The patient was maintained on tube feeds via his G-tube.
He was given swallowing exercises and continued to work with the speech therapy team on techniques to improve his swallowing and allow for eventual advancement of PO intake.
# Code: FULL   Medications on Admission: Acyclovir 400mg [**Hospital1 **] Azithromycin 1,200mg Qweek Diltiazem 30mg QID Fluconazole 200mg daily Flagyl 500mg [**Hospital1 **] Fluticasone 110mcg, 2 puffs [**Hospital1 **] Hydrocodone acetaminophen 5/500, 1-2tabs Q6hr prn Combivent 18/103, 1-2 puffs Q6hr prn Lansoprazole 30mg daily Loperaminde 2mg QID prn Megestrol 400mg [**Hospital1 **] prn Mirtazapine 30mg QHS prn Compazine 10mg Q6hr prn Trazodone 50mg QHS prn Pentamadine Qmonth Tylenol prn Colace prn Senna prn Simethicone prn Multivitamins   Discharge Medications: 1.
Fluconazole 200 mg Tablet [**Hospital1 **]: One (1) Tablet PO once a day.
Lansoprazole 30 mg Tablet,Rapid Dissolve, DR [**Last Name (STitle) **]: One (1) Tablet,Rapid Dissolve, DR [**Last Name (STitle) **] DAILY (Daily): per G-tube.
Docusate Sodium 100 mg Capsule [**Last Name (STitle) **]: One (1) Capsule PO BID (2 times a day) as needed for constipation.
Senna 8.6 mg Tablet [**Last Name (STitle) **]: Two (2) Tablet PO BID (2 times a day) as needed for constipation.
Acyclovir 200 mg/5 mL Suspension [**Last Name (STitle) **]: Four Hundred (400) mg PO every eight (8) hours.
Mirtazapine 30 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO HS (at bedtime): per g-tube.
Trazodone 50 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO HS (at bedtime) as needed for insomnia: per g-tube.
Azithromycin 600 mg Tablet [**Last Name (STitle) **]: Two (2) Tablet PO 1X/WEEK (TU) as needed for mycobacterium: Total is 1200mg per g-tube.
Fludrocortisone 0.1 mg Tablet [**Last Name (STitle) **]: 0.5 Tablet PO DAILY (Daily).
Metoprolol Tartrate 25 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO TID (3 times a day): per g-tube.
Allopurinol 300 mg Tablet [**Last Name (STitle) **]: 0.5 Tablet PO DAILY (Daily): per g-tube.
Portacath), non-heparin dependent: Flush with 10 mL Normal Saline daily, PRN, and when de-accessing, per lumen.
Heparin Flush (100 units/ml) 5 mL IV PRN DE-ACCESSING port Indwelling Port (e.g.
Portacath), heparin dependent: When de-accessing port, instill Heparin as above per lumen.
Heparin Flush (10 units/ml) 5 mL IV PRN line flush Indwelling Port (e.g.
Portacath), heparin dependent: Flush with 10 mL Normal Saline followed by Heparin as above daily and PRN per lumen.
Vancomycin 125 mg Capsule [**Last Name (STitle) **]: One (1) Capsule PO Q6H (every 6 hours): Last dose evening of [**2135-6-4**].
Fluticasone 110 mcg/Actuation Aerosol [**Date Range **]: Two (2) Puff Inhalation [**Hospital1 **] (2 times a day).
Ipratropium Bromide 0.02 % Solution [**Hospital1 **]: One (1) neb Inhalation Q6H (every 6 hours) as needed for shortness of breath or wheezing.
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization [**Hospital1 **]: One (1) neb Inhalation Q6H (every 6 hours) as needed.
Erythromycin 5 mg/g Ointment [**Hospital1 **]: One (1) application Ophthalmic QID (4 times a day) for 6 days: apply to both eyes.
Acetaminophen 160 mg/5 mL Solution [**Hospital1 **]: Six [**Age over 90 1230**]y (650) mg PO Q6H (every 6 hours) as needed for pain, fever.
Ipratropium Bromide 0.02 % Solution [**Age over 90 **]: One (1) neb Inhalation Q8H (every 8 hours).
Has been refractory to multiple chemotherapeutic regimens, currently enrolled on protocol DF#08-019 which is a Phase I/A/II multicenter open label study of HCD122 which is administered intravenously once weekly for 4 weeks -s/p 4 cycles of R-CVP -s/p 4 cycles of R-CHOP -s/p Zevalin in [**7-/2130**] -s/p Rituximab, fludarabine, and mitoxantrone in [**4-/2131**] -s/p 6 cycles bendamustine in [**2-/2132**] -s/p radiation therapy mesenteric mass in [**9-/2133**] -s/p radiation therapy to left pelvic lymphadenopathy causing ureteral obstruction) in [**1-/2134**] -s/p 1 course [**Hospital1 **] [**Date range (1) **]/[**2134**] .
Other Medical History: 1) Mycobacterium xenopi infection since [**2132-12-26**]: Had received one year of Levofloxacin/Azithromycin therapy until [**3-/2134**] with good effect.
Per ID, will need to continue for a total 6 month course (finish [**2135-2-16**]), after which he will be switched to azithromycin alone.
s/p left VATS w wedge resections in [**2133**] for pulmonary nodules 2) C difficile colitis diagnosed during hospitalization in [**9-3**].
He was initially treated on PO metronidazole then converted to PO vancomycin on [**2134-9-22**].
3) During last [**Hospital1 **] admission ([**Date range (1) 32408**]), he had a MRSA UTI, treated with a total of 2 weeks of Vancomycin and then Bactrim.
5) Repeat admission for failure to thrive resulted in PEG tube placement on [**2135-1-5**].
6) Emphysema with smoking history 7) [**2135-3-13**] RSV infection - 10 day course of levofloxacin to prevent regrowth   Discharge Condition: Hemodynamically stable.
You were found to have a MRSA pneumonia for which you were treated with 14 days of an IV antibiotic named vancomycin.
After you finish this treatment (which is vancomycin 4 times a day), you will need to continue this medication twice a day to ensure that the infection does not recur.
You were started on a medication named [**Name (NI) 55852**] with improvement in your blood pressure.
Additionally, you developed conjunctivitis (and eye infection) and were started on an anti-bacterial ointment four times a day.
Please be sure to keep all of your appointments as listed below.
